BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Poxel's First Quarter 2025 Revenue and Business Developments Regulatory Approval Corporate Strategy Poxel Revenue TWYMEEG® Sales Royalties Increase
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Inside Information / Information on annual revenues Poxel reports consolidated revenue and corporate updates for Q1 2025, with TWYMEEG® sales growth in Japan and regulatory approval for diabetic patients with renal impairment Revenue Regulatory Approval Japan Poxel TWYMEEG
BRIEF published on 03/20/2025 at 21:50, 1 year 6 months ago Poxel Releases Positive Preclinical Results for HCM Treatment Preclinical Study Hypertrophic Cardiomyopathy PXL065 Myocardial Remodeling Cardiac Fibrosis
PRESS RELEASE published on 03/20/2025 at 21:45, 1 year 6 months ago Inside Information / Other news releases Poxel announces positive preclinical study results for PXL065, a potential treatment for Hypertrophic Cardiomyopathy, showing benefits in a mouse model Preclinical Study Poxel Hypertrophic Cardiomyopathy PXL065 Mouse Model
BRIEF published on 02/11/2025 at 20:33, 1 year 8 months ago Poxel Holds Combined General Meeting, Announces Key Results General Meeting Shareholder Voting Financial Delegations Remuneration Policy Poxel SA
PRESS RELEASE published on 02/11/2025 at 20:28, 1 year 8 months ago Inside Information / Other news releases Poxel announces results of its Combined General Meeting with approved resolutions on revised remuneration policy for corporate officers. Details available on company's website Voting Results Financial Press Release Combined General Meeting Poxel Remuneration Policy
BRIEF published on 01/31/2025 at 07:35, 1 year 8 months ago POXEL Announces Growing Sales of TWYMEEG in Japan for 2024 Poxel Sumitomo Pharma TWYMEEG Japan Sales 2024 Revenues
BRIEF published on 01/20/2025 at 07:35, 1 year 8 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 8 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 9 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
Published on 10/17/2026 at 03:20, 7 hours 11 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 7 hours 16 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 10 hours 56 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 11 hours 1 minute ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 11 hours 31 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/16/2026 at 20:08, 14 hours 22 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 15 hours 10 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 15 hours 25 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 16 hours 12 minutes ago Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 16 hours 17 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 18:48, 15 hours 42 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/15/2026 at 18:50, 1 day 15 hours ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
